Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 542665 | NSE Symbol : NEOGEN | ISIN : INE136S01016 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
30-Jul-2025	02-Aug-2025	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2025 inter alia to consider and approve Un-audited standalone and consolidated financial results of the Company for the quarter ended on June 30 2025. Outcome of Board Meeting held on August 2, 2025. (As Per BSE Announcement Dated on: 02/08/2025)
09-Jul-2025	12-Jul-2025	Raising funds through Debt Instr.	Inter alia, to consider, evaluate and approve the proposal for raising of funds by way of issue of non-convertible debentures through permissible mode(s), subject to such regulatory and other approvals as may be required in this regard. Approval of Board for Fund raising by way of issue of non- convertible debentures and noting of Notice received from BSE. (As Per BSE Announcement dated on 12.07.2025)
03-Jun-2025	03-Jun-2025	Change in Directors	1) Continuation of Directorship of Prof. Ranjan Kumar Malik 2) Calendar of Events for Postal Ballot 3) Notice received from NSE.
14-May-2025	17-May-2025	Final Dividend	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2025 inter alia to consider and approve inter-alia to consider approve and take on record: 1)Audited Financial Results of the Company for the quarter & FY ended on 31-03-2025; 2)Recommendation of a final dividend if any on the equity shares of the Company for the FY ended 31-03-2025 Outcome of Board Meeting: Recommended a final dividend of Re. 1 per Equity Share for the Financial Year 2024-25, subject to approval of shareholders at the ensuing Annual General Meeting of the Company. Record Date for the purpose of determining members eligible to receive dividend and the date of AGM, shall be intimated in due course (As Per BSE Announcement Dated on 17.05.2025)
25-Mar-2025	25-Mar-2025	Investments	Outcome of Board Meeting - Investment in Neogen Chemicals Japan Corporation Limited.
27-Jan-2025	01-Feb-2025	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2025 inter alia to consider and approve Un-audited financials for the quarter and nine months ended December 31 2024. Outcome of Board Meeting (As Per BSE Announcement Dated on: 01/02/2025)
06-Nov-2024	12-Nov-2024	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Intimation of Board meeting scheduled to be held on November 122024. Board Meeting outcome Unaudited Financial Results Q2FY25 (As Per Bse Announcement Dated on 12.11.2024)
26-Oct-2024	26-Oct-2024	Revision in Directors Remuneration	Outcome of Board Meeting
01-Aug-2024	07-Aug-2024	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday August 7 2024 inter-alia to consider approve and take on record the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2024. Outcome of Board Meeting held on 07-08-2024 (As Per BSE Announcement Dated on: 07/08/2024)
24-Apr-2024	30-Apr-2024	Accounts	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/04/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday April 30 2024 inter-alia to consider approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2024 and to consider recommendation of a final dividend if any on the equity shares of the Company for the financial year ended March 31 2024 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting Approval of Dividend of Rs. 2 per equity share by the Board of Directors of the Company. Outcome of Board meeting Approval of Scheme of Amalgamation of Buli Chemicals India Private Limited - WOS with Neogen Chemicals Limited- Holding company (As Per BSE Announcement Dated on 30.04.2024)
01-Feb-2024	09-Feb-2024	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Friday February 9 2024 inter-alia to consider approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2023 Unaudited results for the quarter and nine months ended December 31, 2023 (As Per BSE Announcement Dated on 10.02.2024) we wish to inform you that the Board of Directors of the Company had at its meeting held today i.e., Friday, February 9, 2024, at 3:00 p.m. and concluded at 9:25 p.m., inter alia considered and approved the following: 1) Unaudited financials for the Quarter and nine months ended 31-12-2023 2)Statement of Deviation/ Variation in utilization of funds ('Statement') as at December 31,2023 3) Incorporation of Wholly Owned Subsidiary ('WOS') in Japan 4) issuance of Corporate Guarantee on behalf of Buli Chemicals India Private Limited, Wholly Owned Subsidiary (WOS) upto Rs. 50 crores and Others. (As Per BSE Announcement Dated on: 09/02/2024)
01-Nov-2023	08-Nov-2023	Accounts	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Pursuant to regulation 29 and 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 as amended from time to time notice is hereby given that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday November 8 2023 inter-alia to consider approve and take on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2023. The Board of Directors of the Company had at its meeting held today i.e., Wednesday, November 8, 2023, inter alia considered and approved the following: 1. Un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30, 2023 2. Subscription of upto 40,00,000 equity shares at a price of Rs. 10 each on rights issue basis of its Wholly Owned Subsidiary i.e., Neogen Ionics Limited. 3.3. Investing by way of Loan up to Rs. 250 Crores in its Wholly Owned Subsidiary (WOS) i.e., Neogen Ionics Limited Approval of Financial Results for the Quarter and Half year ended September 30, 2023 by the Board of Directors in its meeting held on November 8 , 2023 (As per BSE Announcement Dated on 08/11/2023)
30-Sep-2023	05-Oct-2023	Preferential Issue	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/10/2023 inter alia to consider and approve Pursuant to regulation 29 of the Listing Regulations we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday October 5 2023 inter alia to consider evaluate and approve the proposal for raising of funds by way of issue of equity shares in one or more tranche by way of a Preferential Issue. for a consideration and at such price as may be arrived at pursuant to Chapter V of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations 2018 (each as amended from time to time) (ICDR Regulations) read with the applicable provisions of the Companies Act 2013. With regards to the captioned subject and pursuant to Regulation 30(2) read with Para A of Part A of Schedule III the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 ('Listing Regulations'), we wish to inform you that the Board of Directors at their meeting held today i.e. Thursday, October 5, 2023 which commenced at 7:45 P.M. and concluded at 9.45 p.m. inter alia, considered and approved: 1. Issuance of up to 14,42,358 Equity Shares of face value of Rs. 10 each ('Equity Shares') at a price of Rs. 1754.07 per Equity Share including a premium of Rs. 1744.07 per Equity Share, aggregating up to Rs. 2,52,99,96,897 (Rupees Two Hundred and Fifty Two Crore Ninety Nine Lakh Ninety Six Thousand Eight Hundred Ninety Seven only) (As per BSE Announcement Dated on 05/10/2023)
29-Jul-2023	05-Aug-2023	Quarterly Results	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2023 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30 2023. The Board may in its meeting to be held on August 5, 2023 consider, evaluate and approve the alteration of Authorised Capital and consequent alteration of Memorandum of Association of the COmpany in accordance with the Applicable laws and subject to necessary approvals as may be required. (As Per BSE Announcement Dated on 02.08.2023) Board of Directors of the Company had at its meeting held today i.e. Saturday, August 5, 2023, considered and approved the items as mentioned in the attached outcome Board of Directors in its meeting held on August 5, 2023 approved the matters mentioned in the attachment (As Per BSE Announcement Dated on 05.08.2023)
06-May-2023	13-May-2023	Accounts	Neogen Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2023 inter alia to consider and approve Pursuant to regulation 29 and 33 of the Listing Regulations notice is hereby given that a meeting of the Board of Directors of the Company is schedule to be held on Saturday May 13 2023 inter-alia to consider approve and take on record the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on March 31 2023 and to consider recommendation of a final dividend if any on the equity shares of the Company for the financial year ended March 31 2023 subject to declaration and approval of the same by the shareholders at the ensuing Annual General Meeting. 1. Approved the Audited Financial Results (Standalone and Consolidated) of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2023, pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee; Pursuant to Regulation 33(3) (d) of the Listing Regulations, we would like to declare that the Statutory Auditors of the Company M/s. JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2023 with un-modified opinion and a declaration to that effect is enclosed.2. Recommended a final dividend of Rs. 3 per Equity Share for the Financial Year 2022-23, subject to approval of shareholders at the ensuing Annual General Meeting of the Company. (As per BSE Announcement Dated on 13/05/2023)

1 2

LOGIN HERE

Neogen Chemicals Ltd

Board Meeting